Independent clonal origins of distinct tumor foci in multifocal papillary thyroid carcinoma.

BACKGROUND Papillary thyroid carcinoma is frequently multifocal. We investigated whether noncontiguous tumor foci arise from intraglandular metastases from a single primary tumor or originate as unrelated clones derived from independent precursors. METHODS Using a polymerase-chain-reaction assay involving the human androgen receptor gene (HUMARA), we analyzed the patterns of X-chromosome inactivation of multiple distinct foci of well-differentiated multifocal papillary thyroid cancer from 17 women. RESULTS Multiple thyroid tumor foci from 10 of 17 patients yielded DNA of adequate quality and were heterozygous for the HUMARA polymorphism and hence suitable for analysis. A single X chromosome was inactivated in each focus, consistent with its monoclonality. When the specific monoclonal configurations of each patient's discrete tumor foci were compared, discordant patterns indicative of independent origins were observed among the tumors from five patients; results in the remaining five were consistent with either a shared or independent clonal origin. CONCLUSIONS Individual tumor foci in patients with multifocal papillary thyroid cancer often arise as independent tumors.

[1]  Yuri E Nikiforov,et al.  High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma. , 2003, Cancer research.

[2]  J. Fagin,et al.  Clonal composition of benign and malignant human thyroid tumors. , 1990, The Journal of clinical investigation.

[3]  P. Ladenson,et al.  Controversies in the follow-up and management of well-differentiated thyroid cancer. , 2004, Endocrine-related cancer.

[4]  E. White,et al.  Thyroid carcinoma. Classification, intraglandular dissemination, and clinicopathological study based upon whole organ sections of 80 glands , 1963, Cancer.

[5]  C. Hedinger,et al.  Papillary thyroid carcinomas , 1982, Virchows Archiv A.

[6]  M. Borrello,et al.  Frequent activation of ret protooncogene by fusion with a new activating gene in papillary thyroid carcinomas. , 1994, Cancer research.

[7]  Shinichi Suzuki,et al.  BRAF mutations in papillary carcinomas of the thyroid , 2003, Oncogene.

[8]  G. Sozzi,et al.  The two genes generating RET/PTC3 are localized in chromosomal band 10q11.2 , 1994, Genes, chromosomes & cancer.

[9]  M. Borrello,et al.  A t( 10; 17) translocation creates the RET/PTC2 chimeric transforming sequence in papillary thyroid carcinoma , 1994, Genes, chromosomes & cancer.

[10]  I D Hay,et al.  Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype. , 1992, The Journal of clinical investigation.

[11]  B. Vogelstein,et al.  Clonal origin of bladder cancer. , 1992, The New England journal of medicine.

[12]  A. Arnold,et al.  Monoclonality and abnormal parathyroid hormone genes in parathyroid adenomas. , 1988, The New England journal of medicine.

[13]  P. Ladenson,et al.  BRAF mutation in papillary thyroid carcinoma. , 2003, Journal of the National Cancer Institute.

[14]  M. Borrello,et al.  Rearrangements of TRK proto-oncogene in papillary thyroid carcinomas , 1995, Journal of endocrinological investigation.

[15]  I. Hay,et al.  Follicular cell-derived thyroid carcinomas. , 1997, Cancer treatment and research.

[16]  Hawk Wa,et al.  The many appearances of papillary carcinoma of the thyroid. , 1976 .

[17]  L. Sobrinho,et al.  Clonal origin of non-medullary thyroid tumours assessed by non-random X-chromosome inactivation. , 2002, European journal of endocrinology.

[18]  D. Wynford‐Thomas,et al.  How may clonality be assessed in human tumours? , 1994, Histopathology.

[19]  W. Rienhoff.  THE LYMPHATIC VESSELS OF THE THYROID GLAND IN THE DOG AND IN MAN , 1931 .

[20]  A. Kawaoi,et al.  Multiple thyroid involvement (intraglandular metastasis) in papillary thyroid carcinoma. A clinicopathologic study of 105 consecutive patients , 1992, Cancer.

[21]  James Howard Means,et al.  THE THYROID AND ITS DISEASES , 1938 .

[22]  M. Santoro,et al.  PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas , 1990, Cell.

[23]  B. Delahunt,et al.  Thyroid gland clonality revisited: the embryonal patch size of the normal human thyroid gland is very large, suggesting X-chromosome inactivation tumor clonality studies of thyroid tumors have to be interpreted with caution. , 2003, The Journal of clinical endocrinology and metabolism.

[24]  L. E. McDonald,et al.  A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[25]  M. Fey,et al.  Tumour heterogeneity and clonality--an old theme revisited. , 1996, Annals of oncology : official journal of the European Society for Medical Oncology.

[26]  A. Arnold,et al.  Monoclonality of parathyroid tumors in chronic renal failure and in primary parathyroid hyperplasia. , 1995, The Journal of clinical investigation.

[27]  M. Yonekura,et al.  Study of intraglandular dissemination of thyroid cancer , 1969, Cancer.

[28]  E. Kaplan,et al.  N-ras mutation: an independent prognostic factor for aggressiveness of papillary thyroid carcinoma. , 1994, Surgery.

[29]  P. Vigneri,et al.  Rearrangements of RET and NTRK1 tyrosine kinase receptors in papillary thyroid carcinomas. , 1998, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[30]  R. Zaizov,et al.  Inhibition by Retinoic Acid of Myeloid Progenitors in Chronic Myeloid Leukemia and Myeloproliferative Disease: Increased Sensitivity in Blastic Phase of Chronic Myeloid Leukemia , 1988, Pathology.

[31]  T. Kinoshita,et al.  Clonality analysis by methylation-specific PCR for the human androgen-receptor gene (HUMARA-MSP) , 2000, Leukemia.

[32]  P. Kastner,et al.  Heterogeneity in the distribution of RET/PTC rearrangements within individual post-Chernobyl papillary thyroid carcinomas. , 2004, The Journal of clinical endocrinology and metabolism.

[33]  J. Fagin.  Challenging dogma in thyroid cancer molecular genetics--role of RET/PTC and BRAF in tumor initiation. , 2004, The Journal of clinical endocrinology and metabolism.

[34]  S. Asa,et al.  Distinct multiple RET/PTC gene rearrangements in multifocal papillary thyroid neoplasia. , 1998, The Journal of clinical endocrinology and metabolism.

[35]  Z. Piao,et al.  Clinical significance of clonality in thyroid nodules , 1998, The British journal of surgery.

[36]  L. Sobin,et al.  The WHO histological classification of thyroid tumors: A commentary on the second edition , 1989, Cancer.

[37]  S. Jhiang,et al.  Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. , 1994, The American journal of medicine.

[38]  M. Nikiforova,et al.  BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas. , 2003, The Journal of clinical endocrinology and metabolism.